Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00855855 · ClinicalTrials.gov registry record
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 20,830
- Enrollment target
NCT00855855 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 20,830 participants.
The verdict
NCT00855855 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 20,830 participants
- Enrollment target
Study Summary
To monitor the occurrence of invasive Hib disease over time and to determine product-specific rates of invasive Hib disease within the monitored population.
Interventions
- BIOLOGICAL DTaP-IPV/Hib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,830 participants |
| Start Date | 2009-02 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00855855
The ClinicalTrials.gov registry entry for NCT00855855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20,830 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DTaP-IPV/Hib is the first listed.
NCT00855855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00855855 about?
NCT00855855 is a clinical study titled "Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease". To monitor the occurrence of invasive Hib disease over time and to determine product-specific rates of invasive Hib disease within the monitored population.
What is the current status of trial NCT00855855?
This trial is currently completed. The enrollment target is 20,830 participants. The study started on 2009-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00855855?
The interventions under investigation include: DTaP-IPV/Hib (BIOLOGICAL).
Who is sponsoring clinical trial NCT00855855?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.